众为人本 研为创新
全心创药 关爱生命
CN
EN
JP
首页
关于众红
众红简介
众红文化
众红发展
创药研究
创药领域
研发平台
研发管线
临床研究
发明专利
人力资源
聚焦人才
立业众红
学习发展
招贤纳士
咨询我们
商务开发
技术合作
技术转让
投资融资
联系我们
新闻资讯
公司新闻
行业资讯
{pboot:sort scode=}
[sort:name]
{/pboot:sort}
当前位置:
首页
>
{pboot:sort scode=}[sort:name]{/pboot:sort}
News
2023.11.30
Two Phase I Clinical Trials of Anti-allergic and Desensitizing Drug ZHB107-108 Officially Launched
On November 30, 2023, two Phase I clinical trials of ZHB107-108 sublingual tablets, a new drug origi···
2023.04.06
CDE releases the "Guidelines for Clinical Research and Development of Antibody-Drug Conjugates”
On April 6th, the Drug Review Center of the National Medical Products Administration issued the &quo···
2023.03.31
Standards for Accelerating the Evaluation of Innovative Drug Marketing License Applications by the Drug Approval Center
On March 31st,the Drug Approval Center of the State Food and Drug Administration issued a notice on ···
2023.02.11
ISC-2023 International Stroke Conference
The 2023 International Stroke Conference (ISC) has been held in Dallas, Texas, USA from Februar···
2023.01.18
The 2022 ZONHONBIO and GENSUNBIO Annual Meeting and 2023 New Year’s Celebration Came to Successful Conclusion
歌声袅袅辞旧岁,舞姿翩翩贺新春。2023年1月16日,众红京森2022年年会暨2023年迎春联欢会在众红生物多功能厅顺利举行。全体众红京森人济济一堂,回望2022,我们经历了不平凡的一年,面对疫情,我···
2022.12.26
2022 National Allergy Academic Conference of the Chinese Medical Association
The 2022 National Allergy Academic Conference of the Chinese Medical Association, organized by the C···
2022.11.09
CDE releases the "Technical Guidelines for Clinical Research and Development of Bispecific Antibody Antitumor Drugs”
On November 9th, 2022, the Drug Review Center of the National Medical Products Administration issued···
2022.10.16
WAO-28th World Allergy Congress 2022
The 28th World Allergy Congress 2022 (WAC2022) has been held in Istanbul, Turkey, from October 13th-···
首页
1
2
3
4
5
···
尾页